Sign in to view content

Assessing Characteristics of Patients With or Without Intraocular Inflammation (IOI) In the Brolucizumab Treatment Arms From the HAWK and HARRIER, Phase 3 Studies

Jeffrey S. Heier, MD

Video
Published 2020

Related

New Therapeutics for Uveitis and Best Uveitis Cases
Sunil Srivastava, MD
Updates from the Field
2017
Abicipar Phase 2 MAPLE Trial Supports Improved Safety for Patients with nAMD Following a Modified Manufacturing Process
Raj K. Maturi, MD
Updates from the Field
2019
Prospective Use of Imaging Quantification of Inflammation: Determining Uveitis Activity and Correlating to Visual Acuity
Jordan D Deaner, MD
Annual Meeting Talks
2021

Category: Age-Related Macular Degeneration

See more